| Dry column vacuum chromatography DS Pedersen, C Rosenbohm Synthesis 2001 (16), 2431-2434, 2001 | 307 | 2001 |
| Synthesis of locked nucleic acid derivatives MD Sørensen, J Wengel, T Koch, SM Christensen, C Rosenbohm, ... US Patent 7,569,575, 2009 | 299 | 2009 |
| 1, 2, 3‐Triazoles in peptidomimetic chemistry DS Pedersen, A Abell European Journal of Organic Chemistry 2011 (13), 2399-2411, 2011 | 229 | 2011 |
| Oligonucleotides with alternating segments of locked and non-locked nucleotides CA Thrue, C Rosenbohm, HF Hansen, M Westergaard, ND Mikkelsen, ... US Patent 7,687,617, 2010 | 182 | 2010 |
| Quantitative analysis of geraniol, nerol, linalool, and α-terpineol in wine DS Pedersen, DL Capone, GK Skouroumounis, AP Pollnitz, MA Sefton Analytical and bioanalytical chemistry 375, 517-522, 2003 | 106 | 2003 |
| Bitopic ligands and metastable binding sites: opportunities for G protein-coupled receptor (GPCR) medicinal chemistry P Fronik, BI Gaiser, D Sejer Pedersen Journal of medicinal chemistry 60 (10), 4126-4134, 2017 | 92 | 2017 |
| Greening the synthesis of peptide therapeutics: an industrial perspective V Martin, PHG Egelund, H Johansson, ST Le Quement, F Wojcik, ... RSC advances 10 (69), 42457-42492, 2020 | 91 | 2020 |
| Selective inhibition of biotin protein ligase from Staphylococcus aureus TPS Da Costa, W Tieu, MY Yap, NR Pendini, SW Polyak, DS Pedersen, ... Journal of Biological Chemistry 287 (21), 17823-17832, 2012 | 80 | 2012 |
| 3-Substituted 2-phenyl-indoles: privileged structures for medicinal chemistry H Johansson, TB Jørgensen, DE Gloriam, H Bräuner-Osborne, ... RSC advances 3 (3), 945-960, 2013 | 74 | 2013 |
| Synthesis of 2′-amino-LNA: a new strategy C Rosenbohm, SM Christensen, MD Sørensen, DS Pedersen, LE Larsen, ... Organic & biomolecular chemistry 1 (4), 655-663, 2003 | 74 | 2003 |
| Biased agonism of clinically approved μ-opioid receptor agonists and TRV130 is not controlled by binding and signaling kinetics MF Pedersen, TM Wróbel, E Märcher-Rørsted, DS Pedersen, TC Møller, ... Neuropharmacology 166, 107718, 2020 | 73 | 2020 |
| Ultra-high performance liquid chromatography tandem mass spectrometry (UHPLC–MS/MS) for determination of GHB, precursors and metabolites in different specimens: application to … FP Busardò, C Kyriakou, E Marchei, R Pacifici, DS Pedersen, S Pichini Journal of pharmaceutical and biomedical analysis 137, 123-131, 2017 | 72 | 2017 |
| Amino-LNA, thio-LNA and alpha-L-oxy-LN SM Christensen, ND Mikkelsen, M Frieden, HF Hansen, T Koch, ... US Patent 9,045,518, 2015 | 69 | 2015 |
| Identification of a new psychoactive substance in seized material: the synthetic opioid N‐phenyl‐N‐[1‐(2‐phenethyl)piperidin‐4‐yl]prop‐2‐enamide (Acrylfentanyl) T Breindahl, A Kimergård, MF Andreasen, DS Pedersen Drug testing and analysis 9 (3), 415-422, 2017 | 68 | 2017 |
| 5-Benzylidenerhodanine and 5-benzylidene-2-4-thiazolidinedione based antibacterials O Zvarec, SW Polyak, W Tieu, K Kuan, H Dai, DS Pedersen, R Morona, ... Bioorganic & medicinal chemistry letters 22 (8), 2720-2722, 2012 | 60 | 2012 |
| Identification of a new metabolite of GHB: gamma-hydroxybutyric acid glucuronide IN Petersen, C Tortzen, JL Kristensen, DS Pedersen, T Breindahl Journal of analytical toxicology 37 (5), 291-297, 2013 | 56 | 2013 |
| New cholesterol esterase inhibitors based on rhodanine and thiazolidinedione scaffolds S Heng, W Tieu, S Hautmann, K Kuan, DS Pedersen, M Pietsch, ... Bioorganic & medicinal chemistry 19 (24), 7453-7463, 2011 | 53 | 2011 |
| Harnessing polarity and viscosity to identify green binary solvent mixtures as viable alternatives to DMF in solid-phase peptide synthesis V Martin, S Jadhav, PHG Egelund, R Liffert, HJ Castro, T Krüger, ... Green Chemistry 23 (9), 3295-3311, 2021 | 51 | 2021 |
| Aspartame as a co-former in co-amorphous systems W Wu, K Löbmann, J Schnitzkewitz, A Knuhtsen, DS Pedersen, ... International journal of pharmaceutics 549 (1-2), 380-387, 2018 | 49 | 2018 |
| Azide‐and alkyne‐derivatised α‐amino acids H Johansson, DS Pedersen European Journal of Organic Chemistry 2012 (23), 4267-4281, 2012 | 49 | 2012 |
Hans Bräuner-OsborneProfessor of Molecular Pharmacology, University of CopenhagenEmail verificata su sund.ku.dk